Skip to main content

Posts

Drug Repurposing Service Providers Market, 2020-2030 by Roots Analysis

  To order this detailed 250+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html   Key Inclusions §   A detailed assessment of the current market landscape of companies offering drug repurposing services based on several relevant parameters, including year of establishment, company size, location of headquarters, type of company, type of service offered (drug discovery, consulting and others), purpose of repurposing, type of repurposing and technology platform used. §   A detailed analysis of the various partnerships that have been signed within this domain, during the period 2013-2020, along with information on year of partnership, type of partnership, and partner company, type of technology / platform used, and key value drivers (such as target therapeutic area and type of drug molecule) and location of collaborators. §   A review of recent initiatives undertaken by big pharma players across the globe for the disc
Post a Comment
Read more
Recent posts

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

  Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic   Roots Analysis has announced the addition of “ Human Microbiome Market, 2019-2030 ” report to its list of offerings   To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html   The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s). §   Elaborate profiles of key players (established after 2005) that are engaged in the development of microbiome therapeutics. §   A detailed review of the cu
Post a Comment
Read more

The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis

  Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world   Roots Analysis is pleased to announce the publication of its recent study, titled, “ China Pharmaceutical Contract Manufacturing Services Market, 2020-2030 . ”   The report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China. The study also features a detailed analysis, highlighting the capabilities of pharmaceutical CMOs in this region. Amongst other elements, the report features: §   A detailed assessment of the current market landscape of pharmaceutical contract manufacturers in China engaged in the development of active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs).  §   A detailed landscape of
Post a Comment
Read more